F-star Therapeutics, Inc.
FSTX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $79 | $19 | $5 | $15 |
| Short-Term Investments | $0 | $0 | $0 | $33 |
| Receivables | $2 | $4 | $11 | $0 |
| Inventory | -$2 | $3 | $2 | $0 |
| Other Curr. Assets | $6 | $1 | $0 | $2 |
| Total Curr. Assets | $85 | $26 | $19 | $49 |
| Property Plant & Equip (Net) | $4 | $4 | $2 | $2 |
| Goodwill | $15 | $15 | $4 | $0 |
| Intangibles | $19 | $19 | $13 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $17 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $38 | $38 | $19 | $19 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $123 | $64 | $38 | $68 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $5 | $2 |
| Short-Term Debt | $1 | $1 | $16 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $12 | $9 | $2 |
| Total Curr. Liab. | $12 | $17 | $30 | $4 |
| LT Debt | $12 | $3 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $1 | $0 | $0 |
| Other NC Liab. | $2 | $0 | $0 | $9 |
| Total NC Liab. | $14 | $4 | $0 | $9 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26 | $21 | $30 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$78 | -$47 | -$22 | -$102 |
| AOCI | -$2 | -$1 | -$2 | $0 |
| Other Equity | $177 | $91 | $32 | $158 |
| Total Equity | $97 | $43 | $9 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $123 | $64 | $38 | $69 |
| Net Debt | -$65 | -$15 | $11 | -$15 |